Engineered antibodies are key players in therapy, diagnostics and research. In addition to
full size immunoglobulin gamma (IgG) molecules, smaller formats of recombinant …

Antibodies are indispensable tools for basic research as well as diagnostic and therapeutic
applications. Consequently, the development of alternative manufacturing strategies which …

Antibody fragments are used in the clinic as important therapeutic proteins for treatment of
indications where better tissue penetration and less immunogenic molecules are needed …

Recombinant antibodies are highly specific detection probes in research, diagnostics, and
have emerged over the last two decades as the fastest growing class of therapeutic proteins …

Recombinant antibody fragments are being used for the last few years as an important
therapeutic protein to cure various critical and life threatening human diseases. Several …

At present, single-chain variable fragments (scFv) of antibodies are considered one of the
most important tools in human therapies. Wide applications of antibodies are being …

After the appearance of the first FDA‐approved antibody 25 years ago, antibodies have
become major therapeutic agents in the treatment of many human diseases, including …

Background Antibodies have been a pillar of basic research, while their relevance in clinical
diagnostics and therapy is constantly growing. Consequently, the production of both …

Cell-free protein synthesis is of increasing interest for the rapid and high-throughput
synthesis of many proteins, in particular also antibody fragments. In this study, we present a …

Cell‐free protein synthesis (CFPS) systems allow for robust protein expression with easy
manipulation of conditions to improve protein yield and folding. Recent technological …